Search results: Sage Journals

Restricted accessResearch articleFirst published May, 2000

Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

Andrew C. McCreary, Sheila L. Handley

Journal of Psychopharmacology

Restricted accessResearch articleFirst published 2009

Delusion Symptoms and Response to Antipsychotic Treatment are Associated with the 5-HT2A Receptor Polymorphism (102T/C) in Alzheimer's Disease: A 3-Year Follow-up Longitudinal Study

Francesco Angelucci, Sergio Bernardini, Paolo Gravina [...]

Journal of Alzheimer’s Disease

Restricted accessOtherFirst published November, 2009

Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors — a new analysis of data from the archives and implications for improved antimanic treatments

PE Harrison-Read

Journal of Psychopharmacology

Restricted accessResearch articleFirst published December, 2003

Serotoninergic Polymorphisms ( 5-HTTLPR and 5-HT2A ): Association Studies with Psychosis in Alzheimer Disease

A. Rocchi, D. Micheli, R. Ceravolo [...]

Genetic Testing and Molecular Biomarkers

Restricted accessResearch articleFirst published September, 2025

Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?

Jan Kehler, Morten Skøtt Thomsen Lindskov

Journal of Psychopharmacology

Restricted accessResearch articleFirst published December, 2013

5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

Valquíria Camin de Bortoli, Paula Shimene de Melo Yamashita, Hélio Zangrossi

Journal of Psychopharmacology

Restricted accessResearch articleFirst published March, 2006

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain

Eleanor J. Bull, Veronica Porkess, Michael Rigby [...]

Journal of Psychopharmacology

Free accessResearch articleFirst published March, 2002

Blockade of 5-HT2A Receptors by Sarpogrelate Protects the Heart Against Myocardial Infarction in Rats

David Brasil, Rana M. Temsah, Kanwal Kumar [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Restricted accessOtherFirst published July, 1999

Activation is Hallucinogenic and Antagonism is Therapeutic: Role of 5-HT2A Receptors in Atypical Antipsychotic Drug Actions

Bryan L. Roth, David L. Willins, Kurt Kristiansen [...]

The Neuroscientist

Restricted accessResearch articleFirst published July, 2012

The Relationship Between Single Nucleotide Polymorphisms in 5-HT2A Signal Transduction-Related Genes and the Response Efficacy to Selective Serotonin Reuptake Inhibitor Treatments in Chinese Patients with Major Depressive Disorder

Heng-Fen Li, Xue Yu, Kun Yang [...]

Genetic Testing and Molecular Biomarkers

Restricted accessResearch articleFirst published May, 2000

Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

Andrew C. McCreary, Sheila L. Handley

Journal of Psychopharmacology

Restricted accessResearch articleFirst published 2009

Delusion Symptoms and Response to Antipsychotic Treatment are Associated with the 5-HT2A Receptor Polymorphism (102T/C) in Alzheimer's Disease: A 3-Year Follow-up Longitudinal Study

Francesco Angelucci, Sergio Bernardini, Paolo Gravina [...]

Journal of Alzheimer’s Disease

Restricted accessOtherFirst published November, 2009

Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors — a new analysis of data from the archives and implications for improved antimanic treatments

PE Harrison-Read

Journal of Psychopharmacology

Restricted accessResearch articleFirst published December, 2003

Serotoninergic Polymorphisms ( 5-HTTLPR and 5-HT2A ): Association Studies with Psychosis in Alzheimer Disease

A. Rocchi, D. Micheli, R. Ceravolo [...]

Genetic Testing and Molecular Biomarkers

Restricted accessResearch articleFirst published September, 2025

Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?

Jan Kehler, Morten Skøtt Thomsen Lindskov

Journal of Psychopharmacology

Restricted accessResearch articleFirst published December, 2013

5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

Valquíria Camin de Bortoli, Paula Shimene de Melo Yamashita, Hélio Zangrossi

Journal of Psychopharmacology

Restricted accessResearch articleFirst published March, 2006

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain

Eleanor J. Bull, Veronica Porkess, Michael Rigby [...]

Journal of Psychopharmacology

Free accessResearch articleFirst published March, 2002

Blockade of 5-HT2A Receptors by Sarpogrelate Protects the Heart Against Myocardial Infarction in Rats

David Brasil, Rana M. Temsah, Kanwal Kumar [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Restricted accessOtherFirst published July, 1999

Activation is Hallucinogenic and Antagonism is Therapeutic: Role of 5-HT2A Receptors in Atypical Antipsychotic Drug Actions

Bryan L. Roth, David L. Willins, Kurt Kristiansen [...]

The Neuroscientist

Restricted accessResearch articleFirst published July, 2012

The Relationship Between Single Nucleotide Polymorphisms in 5-HT2A Signal Transduction-Related Genes and the Response Efficacy to Selective Serotonin Reuptake Inhibitor Treatments in Chinese Patients with Major Depressive Disorder

Heng-Fen Li, Xue Yu, Kun Yang [...]

Genetic Testing and Molecular Biomarkers